Finance Minister Expects 4.5% Growth in Türkiye This Year

Turkish Minister of Finance Mehmet Simsek speaks on Thursday during the general assembly of the Banks Association of Türkiye. (Asharq Al-Awsat)
Turkish Minister of Finance Mehmet Simsek speaks on Thursday during the general assembly of the Banks Association of Türkiye. (Asharq Al-Awsat)
TT

Finance Minister Expects 4.5% Growth in Türkiye This Year

Turkish Minister of Finance Mehmet Simsek speaks on Thursday during the general assembly of the Banks Association of Türkiye. (Asharq Al-Awsat)
Turkish Minister of Finance Mehmet Simsek speaks on Thursday during the general assembly of the Banks Association of Türkiye. (Asharq Al-Awsat)

Turkish Minister of Finance Mehmet Simsek has said that Ankara expects the nation's economy to grow by around 4.5% in 2023.

“In 2023, we are forecasting a growth rate of around 4.5% despite all global financial problems,” he said, stressing that “the need for establishing a rebalance in the economy is very clear.”

“We will move forward in a system that embraces the principles of free exchange, and floating exchange,” he said on Thursday during the general assembly of the Banks Association of Türkiye.

The global economy is expected to reach 3% during the coming five years, he mentioned.

“Our country grew by 5.4% in real terms on average in the 2003-2022 period,” Simsek noted.

“As I said before, our main principles are transparency, consistency, predictability and complying with international norms,” he said.

"Funds started to flow into our capital markets, all these developments have eased access to foreign financing opportunities and reduced financing costs."

“The country's risk premium has decreased from 700 to around 400 basis points,” Simek said.

He remarked that international credit rating agencies have started to reveal a more optimistic outlook for the Turkish economy, adding one of the agencies raised the Turkish banking system's outlook to stable from negative.

Moody’s expects Türkiye’s economic growth to slow down, with real GDP expanding at 4.2% in 2023, down from 5.6% growth in 2022.

It expects inflation to stay high at 51% in 2023, although down from 72% recorded in 2022.

The Turkish minister also vowed to further strengthen financial stability in the upcoming period. “Simplification and tightening policies will continue,” he added.

Strong domestic demand poses risks through the current account deficit and inflation, Simsek said.

In another context, Türkiye's unemployment rate fell to 9.7% in the second quarter of this year, down to 0.3% compared to the quarter before, the country's statistical authority said Thursday.

The number of unemployed individuals decreased by 73,000 when compared to the quarter earlier, TurkStat added.

The number of those employed in the same period increased by 151,000 and reached 31.5 million, the data revealed.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.